chemist warehouse semaglutide Australian Billionaires' Drugstore Chain Expanding In The U.K Semaglutide: Injection Home Kit –

10.1371/journal.pone.0248103 71 LautatzisM

Zealthy-sourced compounded drugs are prepared by a state-licensed sterile compounding pharmacy, however compounded GLP-1 medications themselves are not FDA-approved

A functional differentiation In the context of obesity treatment, not every patient requires intensive psychological support

Phase 3 TRIUMPH Program (Ongoing) - LIVER AS SECONDARY ENDPOINT Status: Currently ongoing, results expected 2026 TRIUMPH-4 (Completed December 2025): Primary endpoints: Weight loss + osteoarthritis pain Results: 28.7% weight loss at 68 weeks Liver outcomes: Secondary/exploratory endpoints TRIUMPH-2 (Ongoing, expected 2026): Weight loss in obesity + type 2 diabetes Liver outcomes: Secondary endpoints (liver enzymes, possibly imaging) Key Point: TRIUMPH Phase 3 trials are NOT primarily liver-focused